Member Info for EJL7

This should open- 4th item down. http://www.*****************/?s=NOP

Sorry link is here-http://www.*****************/video-hydrocarbon-capital-founder-malcolm-graham-wood-gives-his-views-on-oil-gas/

Only important part is about 04:55 when Graham-Wood mentions NOP's italian presence. Though not encouraging.

There are still some openings. Just heard that Keith Bush(CEO), Nick Morgan(FD), and Graham Heard(Exploration & Technical Director) will be there. Keith is presenting.

Nice to have some news. Drilling 3 new wells during the summer targeting unswept oil at the edges of the reef structures should help them avoid the flooding that they encountered in the first 3 wells. Another good point-"The results to date suggest Northern will be able to meet its forecasts for increasing primary recovery rates by at least five per cent, from the current 17 per cent of the 101 million barrels of oil in place." Would love to hear some comments before tomorrow from some of the knowledgeable guys here. Then I can ask some questions. I'll be going to the Oilbarrel conference tomorrow(Wed. 2 July) at The Brewery, hope they'll be others from the bb. BTW-MSMN is also going to present.

http://oilbarrel.com/news/northern-petroleum-encouraged-by-early-results-from-alberta-reef-play-1

To those who hounded me off the board when I made my comments about Nogel Holdings, etc. I apologised for thinking that I made a grievous mistake in my research. It would now be equitable if those who doubted me would now do the same.

Mikey et al.-I too just heard from Keith & he said the same thing about a Canadian update coming out shortly. As for Italy, the same, mentioned that the Italian environment minister has finally approved some environmental impact assessments, so hopefully they'll work thru the backlog. As for Canada-the tie-in work for the wells will have to wait until winter when the ground is frozen. They've temporarily shut 14-22 because of too high a gas rate, but working on the best option to get it flowing again. The higher oil prices are certainly helping existing production.

Nice to see some great input on the board-many thanks. Was looking at reported EPS of Euro 4.5(approx. 3.59 GBP)-so vs. 168.5, that's a current p/e of about 47. Even let's assume eps grows again over 50%-that's still a prospective p/e of over 31. I agree with all of the other arguments about green power, government support, etc.-but it's still a high valuation. I also want to look at their currency exposure. As said in Chairman's statement-"Despite challenges across the sector and exchange rate volatility impacting the accounting treatment of our reported financial metrics, we are confident that the quality of the underlying assets should deliver substantial value to our shareholders." Borrowing in Euros/USD and selling product in rupees-is always going to be a problem. Also-in future-if they start paying a dividend-as stated in Final Results-" Reported profit after tax increased by 55% to €9.3 million (2013: €6.0 million). Of this, €2.5 million (2013: €1.66 million) was attributed to minority shareholders, mainly the preference share held by Global Environment Emerging Markets Fund III and Government of Singapore Investment Company (GIC) through their subsidiary have invested in the Group at the Mauritius subsidiary level, and GE which invested in Greenko's wind holding company." Nice to have the minority shareholders of that calibre, but they will get paid first.

Well-buy on rumour-sell on the news. Was wondering why sp had moved up over last few weeks! Addition of 50MW of wind assets keeps them right on schedule. Earnings looked good to me on cursory glance-will look into further detail. EBITDA up 90.5% and EPS up 53%-nothing to sneeze at. Can't find Arden's or Investec's forecasts-if someone can find these, would love to know. The following link is a bit old-sorry. http://www.brokerforecasts.com/companies/GKO Frustrating but proves one has to top-slice on rallies(which I did-just wish a bit more). Schiff-this share takes a lot of patience-but good thing is the company is performing well so value should shine thru eventually.

Please note- http://www.eventbrite.co.uk/e/66th-oilbarrel-conference-tickets-11790081451 Northern Pete & Mosman will present amongst others.

Sorry-Orbistim-my mistake.

Schiff-how r u? A pretty quiet board. Welcome Orbitism-nice to have some company here. If you have any financial questions, don't hesitate to email Chris Munden at Tavistock: cmunden@tavistock.co.uk--he's very approachable. We'll have to figure out how to get more eyeballs on this sp. It's a great story-very pc-but they seem to have their act in gear-very well run company. Sensex seems to be topping a bit so doesn't help and rupee weakening. Remember they borrow in Euros/USD, so this can hurt. Thought sp was a little ahead of itself-was hoping a stake being taken, but no RNS. GLA

Have looked into profiles of Adam Reynolds, David Evans and Stephen Little. At a glance, all seem pretty competent in their respective fields. Only flag that comes up is for Rupert Lywood. He & David Royds set up Matrix Group(VC, asset management, etc.) in 1987 & had built up stakes of about £ 73 million each in the company. Matrix went into administration in 2012. From the few comments I have read on websites, they supposedly left a number of investors high & dry. This is only hearsay but was just wondering if anyone had heard anymore about the bankruptcy. Might not mean anything-just a flag.

A possible competitor to NIPT-this is from Canada-chromosomal microarray-will have to check whether Premaitha might be taking this direction eventually. http://healthydebate.ca/2014/05/topic/non-invasive-prenatal-testing Enough for tonite-sorry to hog the bb.

Illumina in San Diego, Calif. produces NIPT & sells it into Europe. Premaitha said that they would target the laboratories instead of end customers-will have to check which customers Illumina sells to- http://investor.illumina.com/phoenix.zhtml?c=121127&p=irol-newsArticle&ID=1904020&highlight=

On the Royal College of Obstetricians & Gynaecologists website-dated 5-3-14: "The UK National Screening Committee (UK NSC) is currently working with clinicians to trial the use of Non-Invasive Prenatal Testing (NIPT) in the NHS and will make a formal recommendation on whether to introduce the test when the results of the trial are known"

More on non-invasive prenatal diagnosis- http://www.rapid.nhs.uk/what-is-nipd-nipt/

Poetical et al. Only correction to make-5th paragraph-should be 750 born to Downs last year. Agree that if they can get a jump on the market, can get first mover advantage. They also mention in the admission docs. that they want to be on the diagnostic side of the biz, not the pharmaceutical-much quicker getting product to market-also easier to break into the biz. Further in the docs. they did mention- "Future directions As Premaitha builds and commercialises the IONA® Test, the Directors and Proposed Directors believe that the Company is not only building a valuable in vitro diagnostic product in its own right but also establishing a template for creating valuable diagnostic content on third parties' next generation sequencing systems. The Directors and the Proposed Directors believe there are many other potential clinical applications of next generation sequencing technology and that as these emerge Premaitha will be in a position to capitalise upon them. The most likely applications appear to be next generation sequencing technology for therapy selection in cancer (personalised medicine) or for early cancer detection or monitoring. Premaitha does not intend to establish research activities to discover new markers, rather it intends to use its capabilities in in vitro diagnostic development and manufacture to take biomarkers identified elsewhere and translate these into valuable clinical content which can be used to improve human health." This dovetails into your remark about future screening for genetic markers. 2 other things-my wife & I went thru the same amniocentesis treatment for my youngest daughter-I wouldn't wish that on anyone. Am wondering whether we might see some competition from U.S. firms over here-will have to check that.

kmh- From the admission docs- If the special resolution to approve the change of name of the Company is passed at the General Meeting, the Company's AIM symbol will be changed to NIPT ('Non-Invasive Prenatal Testing') and its website address will be changed to www.premaitha.com following the General Meeting. So will have to wait until about 4 July for new shares to trade from what I understand-anybody else confirm this?